Gemifloxacin
Gemifloxacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Currently not available in the U.S. due to legal dispute related to license to manufacture and distribute (FDA notice-Gemifloxacin )
- Community acquired pneumonia (CAP) caused by S. pneumoniae (including multi-drug resistant strains), H. influenzae, M. catarrhalis, M. pneumoniae, C. pneumoniae, or K. pneumoniae
- Acute bacterial exacerbation of chronic bronchitis (AECB) caused by S. pneumoniae, H. influenzae, H. parainfluenzae, or M. catarrhalis
- Use for AECB should be avoided due recent FDA warning (Black Box warning) regarding serious and potentially permanent side effects (tendonitis and tendon rupture, peripheral neuropathy, and CNS side effects). See FDA safety warning regarding fluoroquinolone use.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --